Cargando…

Time from symptom onset to severe COVID-19 and risk factors among patients in Southern Ethiopia: a survival analysis

OBJECTIVE: This study aimed to assess the time to severe coronavirus disease 2019 (COVID-19) and risk factors among confirmed COVID-19 cases in Southern Ethiopia. METHOD: This two-center retrospective cohort study involved patients with confirmed COVID-19 from 1 October 2020 to 30 September 2021. Ka...

Descripción completa

Detalles Bibliográficos
Autores principales: Sisay, Gizaw, Mantefardo, Bahru, Beyene, Aster
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425909/
https://www.ncbi.nlm.nih.gov/pubmed/36036178
http://dx.doi.org/10.1177/03000605221119366
_version_ 1784778563090644992
author Sisay, Gizaw
Mantefardo, Bahru
Beyene, Aster
author_facet Sisay, Gizaw
Mantefardo, Bahru
Beyene, Aster
author_sort Sisay, Gizaw
collection PubMed
description OBJECTIVE: This study aimed to assess the time to severe coronavirus disease 2019 (COVID-19) and risk factors among confirmed COVID-19 cases in Southern Ethiopia. METHOD: This two-center retrospective cohort study involved patients with confirmed COVID-19 from 1 October 2020 to 30 September 2021. Kaplan–Meier graphs and log-rank tests were used to determine the pattern of COVID-19 severity among categories of variables. Bivariable and multivariable Cox proportional regression models were used to identify the risk factors of severe COVID-19. RESULTS: Four hundred thirteen patients with COVID-19 with a mean age of 41.9 ± 15.3 years were involved in the study. There were 194 severe cases (46.9.1%), including 77 (39.6%) deaths. The median time from symptom onset to severe COVID-19 was 8 days (interquartile range: 7–12 days). The risk factors for severe COVID-19 were age >65 (adjusted hazard ratio [AHR] = 2.65, 95% confidence interval [95%CI]: 1.02, 3.72), cough (AHR = 1.59, 95%CI: 1.39, 2.84), chest pain (AHR = 1.47, 95%CI: 1.34, 2.66), headache (AHR = 2.04, 95%CI: 1.43, 2.88), comorbidity (AHR = 1.3, 95%CI: 1.01, 2.04), asthma (AHR = 1.6. 95%CI: 1.04, 2.24), and symptom onset to admission more than 5 days (AHR = 0.48, 95%CI: 0.34, 0.68). CONCLUSION: Patients with symptoms and comorbidities should be closely monitored.
format Online
Article
Text
id pubmed-9425909
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-94259092022-08-31 Time from symptom onset to severe COVID-19 and risk factors among patients in Southern Ethiopia: a survival analysis Sisay, Gizaw Mantefardo, Bahru Beyene, Aster J Int Med Res Retrospective Clinical Research Report OBJECTIVE: This study aimed to assess the time to severe coronavirus disease 2019 (COVID-19) and risk factors among confirmed COVID-19 cases in Southern Ethiopia. METHOD: This two-center retrospective cohort study involved patients with confirmed COVID-19 from 1 October 2020 to 30 September 2021. Kaplan–Meier graphs and log-rank tests were used to determine the pattern of COVID-19 severity among categories of variables. Bivariable and multivariable Cox proportional regression models were used to identify the risk factors of severe COVID-19. RESULTS: Four hundred thirteen patients with COVID-19 with a mean age of 41.9 ± 15.3 years were involved in the study. There were 194 severe cases (46.9.1%), including 77 (39.6%) deaths. The median time from symptom onset to severe COVID-19 was 8 days (interquartile range: 7–12 days). The risk factors for severe COVID-19 were age >65 (adjusted hazard ratio [AHR] = 2.65, 95% confidence interval [95%CI]: 1.02, 3.72), cough (AHR = 1.59, 95%CI: 1.39, 2.84), chest pain (AHR = 1.47, 95%CI: 1.34, 2.66), headache (AHR = 2.04, 95%CI: 1.43, 2.88), comorbidity (AHR = 1.3, 95%CI: 1.01, 2.04), asthma (AHR = 1.6. 95%CI: 1.04, 2.24), and symptom onset to admission more than 5 days (AHR = 0.48, 95%CI: 0.34, 0.68). CONCLUSION: Patients with symptoms and comorbidities should be closely monitored. SAGE Publications 2022-08-28 /pmc/articles/PMC9425909/ /pubmed/36036178 http://dx.doi.org/10.1177/03000605221119366 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Retrospective Clinical Research Report
Sisay, Gizaw
Mantefardo, Bahru
Beyene, Aster
Time from symptom onset to severe COVID-19 and risk factors among patients in Southern Ethiopia: a survival analysis
title Time from symptom onset to severe COVID-19 and risk factors among patients in Southern Ethiopia: a survival analysis
title_full Time from symptom onset to severe COVID-19 and risk factors among patients in Southern Ethiopia: a survival analysis
title_fullStr Time from symptom onset to severe COVID-19 and risk factors among patients in Southern Ethiopia: a survival analysis
title_full_unstemmed Time from symptom onset to severe COVID-19 and risk factors among patients in Southern Ethiopia: a survival analysis
title_short Time from symptom onset to severe COVID-19 and risk factors among patients in Southern Ethiopia: a survival analysis
title_sort time from symptom onset to severe covid-19 and risk factors among patients in southern ethiopia: a survival analysis
topic Retrospective Clinical Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425909/
https://www.ncbi.nlm.nih.gov/pubmed/36036178
http://dx.doi.org/10.1177/03000605221119366
work_keys_str_mv AT sisaygizaw timefromsymptomonsettoseverecovid19andriskfactorsamongpatientsinsouthernethiopiaasurvivalanalysis
AT mantefardobahru timefromsymptomonsettoseverecovid19andriskfactorsamongpatientsinsouthernethiopiaasurvivalanalysis
AT beyeneaster timefromsymptomonsettoseverecovid19andriskfactorsamongpatientsinsouthernethiopiaasurvivalanalysis